Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study

Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study

Abstract Background Non-typeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis (Mcat) infections are frequently associated with exacerbations of chronic obstructive pulmonary disease (COPD). Results were reported with a two-dose (0–2 months) schedule of an investigational AS01E-adjuvanted...

Full description

Bibliographic Details
Main Authors: Ilaria Galgani, Margherita Annaratone, Daniela Casula, Gennaro Di Maro, Michel Janssens, Annaelisa Tasciotti, Tino Schwarz, Murdo Ferguson, Ashwani Kumar Arora
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Respiratory Research
Subjects:
Non-typeable Haemophilus influenzae
Moraxella catarrhalis
COPD
Exacerbation
Vaccination
Immunogenicity
Online Access:https://doi.org/10.1186/s12931-022-02019-4

Internet

https://doi.org/10.1186/s12931-022-02019-4

Similar Items